Our recent analysis “Early Payer Scientific Advice Procedures In The EU: Which One Is Most Suited For Pharmaceutical Companies” was presented at ISPOR’s 21th annual international meeting in Vienna.
The analysis compared the different methods of seeking payer scientific advice, including EMA joint scientific advice, EUnetHTA and seeking individual country payer advice.